Search results for "Sertraline"

showing 9 items of 19 documents

Effect of sertraline treatment on benzodiazepine receptors in the rat brain.

1993

In this paper we describe the modification of benzodiazepine (BDZ) binding sites in the rat brain after different times of treatment with the 5-hydroxytryptamine-(5HT) uptake blocker sertraline. We investigated the effect of 8, 15 and 30 days sertraline treatment (10 mg/kg/day, i.p.) on 3 H-flunitrazepam binding sites. In order to describe the anatomical site of action of the drug, the experiment has been carried out by means of quantitative receptor autoradiography. After 8 days of sertraline treatment, an increase of BDZ receptor density is found in the olfactory tubercle. This effect is reversed at 15 and 30 days. At 15 days of treatment, an increase is found in the anterior cingulate co…

Malemedicine.medical_specialtymedicine.drug_classRats Sprague-DawleyInternal medicineSertralinemedicineLimbic SystemAnimalsReceptorBiological Psychiatry5-HT receptorBrain ChemistryCerebral CortexBenzodiazepineSertralineBehavior AnimalGABAA receptorChemistryOlfactory tubercleBody WeightSeptal nucleiOlfactory PathwaysReceptors GABA-AAntidepressive AgentsRatsPsychiatry and Mental healthmedicine.anatomical_structureEndocrinology1-NaphthylamineNeurologyAnti-Anxiety AgentsCerebral cortexNeurology (clinical)Selective Serotonin Reuptake Inhibitorsmedicine.drugJournal of neural transmission. General section
researchProduct

Anodal tDCS over the left prefrontal cortex does not cause clinically significant changes in circulating metabolites

2020

Background: Transcranial direct current stimulation (tDCS), a putative treatment for depression, has been proposed to affect peripheral metabolism. Metabolic products from brain tissue may also cross the blood–brain barrier, reflecting the conditions in the brain. However, there are no previous data regarding the effect of tDCS on circulating metabolites.\ud Objective: To determine whether five daily sessions of tDCS modulate peripheral metabolites in healthy adult men.\ud Methods: This double-blind, randomized controlled trial involved 79 healthy males (aged 20–40 years) divided into two groups, one receiving tDCS (2 mA) and the other sham stimulated. The anode was placed over the left dor…

Metabolitemedicine.medical_treatmentPhysiologyStimulationSELECT-TDCS3124 Neurology and psychiatrylaw.inventionchemistry.chemical_compound0302 clinical medicineRandomized controlled triallawlcsh:PsychiatryMedicineaivotutkimustESMOTOR CORTEXaineenvaihduntaTRANSCRANIAL DC STIMULATIONOriginal Researchmass spectrometryPsychiatryTranscranial direct-current stimulationVenous bloodDEPRESSION3. Good healthPeripheralPsychiatry and Mental healthmedicine.anatomical_structureMENSTRUAL-CYCLEaivotMotor cortexmasennuslcsh:RC435-571brain stimulationSERTRALINE03 medical and health sciencesMETAANALYSISbusiness.industryDIRECT-CURRENT STIMULATIONEFFICACYneurotieteet030227 psychiatryBRAIN-STIMULATIONaivokuorichemistryBrain stimulationaineenvaihduntatuotteettranscranial direct current stimulationbusinessmetabolism030217 neurology & neurosurgery
researchProduct

Asymmetric Allylation/Ring Closing Metathesis: One-Pot Synthesis of Benzo-fused Cyclic Homoallylic Amines. Application to the Formal Synthesis of Ser…

2013

A one-pot asymmetric allylation/ring closing metathesis (RCM) sequence for the synthesis of cyclic homoallylic amines has been developed. A library of six- and seven-membered benzo-fused products has been synthesized in good yields and complete diastereoselectivity. The new methodology has been applied to the formal syntheses of the antidepressant Sertraline and the epimeric Norsertraline. The methodology is amenable for the synthesis of analogs.

Molecular StructureChemistryOrganic ChemistryOne-pot synthesisStereoisomerismStereoisomerismBiochemistryCatalysisFormal synthesisRing-closing metathesisSertralineOrganic chemistryAminesPhysical and Theoretical Chemistry
researchProduct

Fluvoxamine but not sertraline inhibits the metabolism of olanzapine: evidence from a therapeutic drug monitoring service.

2001

Therapeutic drug monitoring data of the new atypical neuroleptic drug olanzapine were used to study interactions with the selective serotonin reuptake inhibitors fluvoxamine and sertraline. The distribution of the ratio of concentration/daily dose (C/D; ng/mL per mg/d) of olanzapine was compared in three groups: patients treated with olanzapine (n = 134), patients treated with olanzapine plus fluvoxamine (n = 10) concomitantly, and patients treated with olanzapine plus sertraline (n = 21) concomitantly. No significant difference was seen between the olanzapine and the olanzapine plus sertraline groups. Patients receiving fluvoxamine in addition to olanzapine had C/D ratios that were in the …

OlanzapineAdultMaleFluvoxaminePharmacologyBenzodiazepinesPharmacokineticsCytochrome P-450 Enzyme SystemSertralineMedicineHumansPharmacology (medical)Drug InteractionsAdverse effectChromatography High Pressure LiquidAgedPharmacologySertralineDepressive Disordermedicine.diagnostic_testbusiness.industryPirenzepineDrug interactionMiddle AgedLiverTherapeutic drug monitoringFluvoxamineOlanzapineAntidepressive Agents Second-GenerationFemaleDrug MonitoringbusinessReuptake inhibitorSelective Serotonin Reuptake Inhibitorsmedicine.drugTherapeutic drug monitoring
researchProduct

P-491 - Sensitivity to changes during antidepressant treatment: a comparison of unidimensional depression rating scales in patients with minor depres…

2012

In the efficacy evaluation of antidepressant treatments the total score of the Hamilton Depression Rating Scale (HAMD) is still regarded as the’gold standard’. Studies suggest that unidimensional subscales of the HAMD, which capture the core depressive symptoms, outperform the full HAMD regarding the detection of antidepressant treatment effects. The present study compared several unidimensional subscales of the HAMD and the Inventory of Depressive Symptomatology (IDS) regarding their sensitivity to changes in depression symptoms in a sample of patients with minor depression (MIND). Biweekly IDS-C28 and HAMD17 data from 287 patients of a 10-week randomised, placebo-controlled trial comparin…

Sertralinemedicine.medical_specialtymedicine.medical_treatmentShort scaleGroup psychotherapyPsychiatry and Mental healthRating scaleHamdmedicineAntidepressantIn patientPsychologyPsychiatryDepression (differential diagnoses)Clinical psychologymedicine.drugEuropean Psychiatry
researchProduct

A conceptually new treatment approach for relapsed glioblastoma: Coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the …

2013

Kast, Richard E. et al.

medicine.medical_specialtyCaptoprilTel avivMorpholinesArtesunateReviewGluconatesAngiotensinQuality of lifeAuranofinSertralineAntineoplastic Combined Chemotherapy ProtocolsDisulfiramTemozolomidemedicineRecurrent diseaseHumansIn patientNelfinavirTemozolomideBrain Neoplasmsbusiness.industrySuccinatesNeurokininCytotoxic chemotherapyUniversity hospitalmedicine.diseaseArtemisininsSurgeryDacarbazineKetoconazoleOncologyangiotensin aprepitant artesunate auranofin captopril cytokines disulfiram glioblastoma ketoconazole nelfinavir neurokinin sertraline temozolomideFamily medicineCytokinesNeoplasm Recurrence LocalGlioblastomabusinessAprepitantGlioblastomamedicine.drugOncotarget
researchProduct

Treatment of Comorbid Alcohol Dependence and Anxiety Disorder: Review of the Scientific Evidence and Recommendations for Treatment.

2017

Producción Científica

medicine.medical_specialtylcsh:RC435-571Alcohol use disorderReviewTrastorno de ansiedadTrastorno por consumo de alcoholco-occurring disorders03 medical and health sciences0302 clinical medicinePrevalence of mental disordersanxiety disorderslcsh:Psychiatrymental disordersmedicinePsychiatryPsychiatrySertralineSocial anxietyAlcohol dependencealcohol-use disorderComorbilidadmedicine.diseaseParoxetineComorbidity030227 psychiatryPsychiatry and Mental healthcomorbiditytreatment recommendationsTrastornos concurrentesPsychology030217 neurology & neurosurgeryAnxiety disordermedicine.drugClinical psychology
researchProduct

Five Interpersonal Factors Are Predictive of the Response to Treatment of Major Depression With Antidepressants in Primary Care

2018

Introduction: Factors relating to the interpersonal relationship between the patient and their physician and social environment are important components, which contribute to their response to treatment for major depressive disorder. This study aimed to assess the influence of optimism, perfectionism, therapeutic alliance, empathy, social support, and adherence to medication regimen in the response to antidepressant treatments in the context of normal primary care clinical practice.Method: We conducted a prospective study in which 24 primary care physicians administered sertraline or escitalopram to 89 patients diagnosed with major depressive disorder. The response to treatment and remission…

medicine.medical_specialtylcsh:RC435-571psiquiatriaContext (language use)malalties mentals03 medical and health sciencesSocial supportprimary care0302 clinical medicinelcsh:PsychiatryInternal medicineMedicineEscitalopram030212 general & internal medicineProspective cohort studyempathyOriginal ResearchPsychiatrySertralinebusiness.industrytherapeutic alliancePrimary care physicianSocial environmentsocial supportmedicine.diseaseoptimismPsychiatry and Mental healthantidepressantsMajor depressive disorderperfectionismbusiness030217 neurology & neurosurgerymedicine.drugFrontiers in Psychiatry
researchProduct

Is Sertraline a Good Pharmacological Strategy to Control Anger? Results of a Systematic Review

2019

Introduction: Extensive research has made it possible to conclude that dysfunctions in serotoninergic transmission are associated with a tendency toward violence and behavioral dysregulations in humans. In this regard, it has been suggested that selective serotonin reuptake inhibitors (SSRIs), such as sertraline, which regulate the serotonin system, might reduce proneness to violence. Aims: This review aims to explore changes in feelings of anger-state (e.g., irritability and hostility) and anger expression as primary outcomes after sertraline treatment. Methods: Based on PRISMA quality criteria for reviews, a literature search was carried out through PubMed, PsycINFO, Dialnet, Psicodoc, We…

medicine.medical_specialtymedia_common.quotation_subjectlcsh:BF1-990HostilityPsycINFOReviewDevelopmentCochrane LibraryAngerIrritability03 medical and health sciencesBehavioral Neuroscienceviolence0302 clinical medicinesystematic reviewGeneticsmedicine030212 general & internal medicinePsychiatryGeneral PsychologyEcology Evolution Behavior and Systematicsmedia_commonSertralinetreatmentbusiness.industrysertralinedrugClinical trialMoodlcsh:Psychologymedicine.symptombusiness030217 neurology & neurosurgerymedicine.drugBehavioral Sciences
researchProduct